📰 Evercore Group News
Page 17 - Evercore Group News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Evercore Group. Real-time updates on events, politics, business and more.
February 23, 2023
WALTHAM, Mass., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc., (Nasdaq:APLS), a global biopharmaceutical company and leader in...
February 22, 2023
WALTHAM, Mass., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc., (Nasdaq:APLS), a global biopharmaceutical company and leader in...
February 15, 2023
Avaya Holdings Corp., a global leader in solutions to enhance and simplify communications and collaboration, has entered into a Restructuring Support Agreement (the “Financial Restructuring”) with overwhelming support of more than 90% of the Company’s secured lenders (the “Investor Group”). Implementing the Financial Restructuring will accelerate...
February 15, 2023
Funding for restructure secured.
February 15, 2023
Avaya Holdings Corp. has filed for Chapter 11 bankruptcy and secured a financing of $780 million as it ...
February 15, 2023
The UC giant listed in its filing unsecured claims valued in millions from the likes of Verint Americas, Microsoft and solution provider giant SHI International
February 14, 2023
Secures Approximately $780 Million in Committed Financing; New Capital Will Accelerate Investment in Avaya’s Leading Cloud Communications Portfolio Enters Agreement to Eliminate More Than 75% of Debt and Substantially Increase Cash and Liquidity Initiates Expedited, Prepackaged Financial Restructuring via Chapter 11 with Overwhelming Support of Financial Stakeholders Expects to Complete Process in 60 to 90 Days; Paying Vendors and Suppliers in Full and Paying Employees as Usual Extends and...
February 10, 2023
RADNOR, Pa., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on...
February 3, 2023
/PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it has priced a public offering of...
February 2, 2023
BRISBANE, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc., (NasdaqGM: VERA; “Vera”), a late-stage biotechnology company focused on...